SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
Datum | Rating | Analyst | |
---|---|---|---|
09.10.17 | Roche Neutral | UBS AG | |
06.10.17 | Roche Equal-Weight | Morgan Stanley | |
05.10.17 | Roche overweight | JP Morgan Chase & Co. | |
04.10.17 | Roche Hold | Deutsche Bank AG | |
04.10.17 | Novartis Hold | Deutsche Bank AG | |
02.10.17 | Roche overweight | JP Morgan Chase & Co. | |
02.10.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
26.09.17 | Novartis Neutral | JP Morgan Chase & Co. | |
25.09.17 | Roche Underperform | BNP PARIBAS | |
25.09.17 | Roche overweight | JP Morgan Chase & Co. | |
21.09.17 | Roche buy | Jefferies & Company Inc. | |
21.09.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
19.09.17 | Novartis kaufen | HSBC | |
15.09.17 | Roche Reduce | HSBC | |
13.09.17 | Roche overweight | Barclays Capital | |
13.09.17 | Roche overweight | JP Morgan Chase & Co. | |
12.09.17 | Roche Hold | Baader Bank | |
12.09.17 | Roche Reduce | HSBC | |
11.09.17 | Roche Hold | Deutsche Bank AG | |
11.09.17 | Roche overweight | JP Morgan Chase & Co. | |
11.09.17 | Roche overweight | JP Morgan Chase & Co. | |
11.09.17 | Roche Hold | Kepler Cheuvreux | |
11.09.17 | Roche Outperform | Credit Suisse Group | |
11.09.17 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
07.09.17 | Novartis buy | HSBC | |
05.09.17 | Novartis Neutral | JP Morgan Chase & Co. | |
05.09.17 | Roche Neutral | UBS AG | |
29.08.17 | Novartis Neutral | JP Morgan Chase & Co. | |
28.08.17 | Novartis Neutral | UBS AG | |
28.08.17 | Novartis buy | Kepler Cheuvreux | |
24.08.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
15.08.17 | Roche buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.08.17 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
08.08.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
04.08.17 | Novartis buy | Baader Bank | |
31.07.17 | Roche overweight | JP Morgan Chase & Co. | |
28.07.17 | Roche overweight | JP Morgan Chase & Co. | |
28.07.17 | Roche Hold | Deutsche Bank AG | |
27.07.17 | Roche Neutral | UBS AG | |
27.07.17 | Roche Outperform | Bernstein Research |